Mckinsey agreed to pay $650 million to settle the criminal investigation of opioids by the U.S. Department of Justice. Mckinsey submitted a five-year deferred prosecution agreement to the federal court in Abingdon, Virginia, and agreed to pay $650 million to settle the criminal investigation of the U.S. Department of Justice on its work in guiding the opioid manufacturer Purdue Pharmaceutical to increase sales. According to court documents, Martin Elling, a former senior partner of McKinsey, agreed to plead guilty to obstruction of justice because he destroyed McKinsey's consulting records for Purdue Pharmaceutical. He will plead guilty on January 10th next year. Mckinsey has previously reached various settlement agreements totaling nearly $1 billion. The company had previously faced lawsuits in several States in the United States, and was accused of providing sales analysis and marketing advice to pharmaceutical companies such as Purdue Pharmaceutical and Johnson & Johnson, which contributed to the popularity of opioids.Shenzhen Stock Exchange: Focus on monitoring "*ST Tongzhou", whose stock price has been fluctuating abnormally recently. Shenzhen Stock Exchange: From December 9 to December 13, this Exchange took self-regulatory measures on 171 abnormal securities trading behaviors, involving abnormal trading situations such as intraday pulling up and suppressing, false declaration, etc. Focus on monitoring "*ST Tongzhou" with abnormal stock price fluctuation recently; A total of 9 major events of listed companies were verified, and 3 clues of suspected illegal cases were reported to the CSRC.Faba Bank: The Fed will formulate policies in consideration of inflation risks. Economists at Faba Bank wrote that it may be difficult for Fed officials to formulate and discuss monetary policies "without being involved in the debate on President-elect Trump's potential economic policies". They expect FOMC to cut interest rates by 25 basis points next week, as reflected by the market. They added that Federal Reserve Chairman Powell "may use the press conference to provide options for further relaxing the suspension of monetary policy." They don't expect him to directly comment on Trump's policies, "but FOMC will formulate policies consistent with managing high inflation risks," economists said.
Jiaying Pharmaceutical Co., Ltd.: The chairman of the board proposed to buy back the company's shares of no more than 132.3 million yuan. On the evening of December 13, Jiaying Pharmaceutical announced that Li Neng, the chairman of the company, proposed that the company buy back some RMB common shares (A shares) issued by the company through the trading system of Shenzhen Stock Exchange with its own funds, and the repurchased shares are intended to be used for implementing employee stock ownership plan or equity incentive. According to the proposal, combined with the company's financial operation and actual situation, the number of shares to be repurchased this time is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; It does not exceed 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. According to the calculation that the maximum number of repurchased shares is 13.5 million shares (inclusive) and the maximum price of repurchased shares is 9.80 yuan/share (inclusive), the total amount of repurchased shares does not exceed 132.3 million yuan (inclusive).Jiaying Pharmaceutical Co., Ltd.: The chairman of the board proposed to buy back the company's shares of no more than 132.3 million yuan. On the evening of December 13, Jiaying Pharmaceutical announced that Li Neng, the chairman of the company, proposed that the company buy back some RMB common shares (A shares) issued by the company through the trading system of Shenzhen Stock Exchange with its own funds, and the repurchased shares are intended to be used for implementing employee stock ownership plan or equity incentive. According to the proposal, combined with the company's financial operation and actual situation, the number of shares to be repurchased this time is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; It does not exceed 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. According to the calculation that the maximum number of repurchased shares is 13.5 million shares (inclusive) and the maximum price of repurchased shares is 9.80 yuan/share (inclusive), the total amount of repurchased shares does not exceed 132.3 million yuan (inclusive).According to HKEx documents, Ganyuan Weike Holdings Co., Ltd. submitted an application for listing to HKEx.
Liard: In the future, it is possible to integrate algorithms with AI chips to improve the control ability of robot limbs. Liard said on the conference call that the company has actually been an optical camera for many years, and the technology of this company is still relatively mature. This belongs to the hardware. In the future, it is possible to integrate the algorithm with the current AI chip more. After the integration of this chip with partners, the local computing power of the robot will be improved, and then the limb control ability of the robot will be improved.Broadcom rose more than 18% at the beginning, Broadcom rose more than 18% at the beginning, and the total market value rose to $1 trillion. The company's Q4 profit exceeded expectations, and its AI revenue doubled and rose by 220% in the whole fiscal year.Puyin AXA Fund: Zhang Jian is the new chairman of the company. On December 13th, Puyin AXA Fund announced that since December 13th, Zhang Jian has been the new chairman of the company, while Xie Wei, the former chairman, left his post on December 13th due to work arrangements, and there is no explanation for his transfer to other positions in the company.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide